Authors:
Fellermann, K
Rudolph, B
Witthoft, T
Herrlinger, KR
Tronnier, M
Ludwig, D
Stange, EF
Citation: K. Fellermann et al., Sweet syndrome and erythema nodosum in steroid-refractory ulcerative colitis: Successful treatment with tacrolimus, MED KLIN, 96(2), 2001, pp. 105-108
Authors:
Herrlinger, KR
Noftz, MK
Fellermann, K
Schmidt, K
Steinhoff, J
Stange, EF
Citation: Kr. Herrlinger et al., Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use, ALIM PHARM, 15(3), 2001, pp. 363-369
Authors:
Fellermann, K
Herrlinger, KR
Witthoeft, T
Homann, N
Ludwig, D
Stange, EF
Citation: K. Fellermann et al., Tacrolimus: A new immunosuppressant for steroid refractory inflammatory bowel disease, TRANSPLAN P, 33(3), 2001, pp. 2247-2248
Authors:
Fellermann, K
Steffen, M
Stein, J
Raedler, A
Hamling, J
Ludwig, D
Loeschke, K
Stange, EF
Citation: K. Fellermann et al., Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease, ALIM PHARM, 14(2), 2000, pp. 171-176
Citation: K. Fellermann et Ef. Stange, Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology?, HEP-GASTRO, 47(35), 2000, pp. 1422-1424
Authors:
Ludwig, D
Stahl, M
Ibrahim, ME
Wenzel, BE
Drabicki, D
Wecke, A
Fellermann, K
Stange, EF
Citation: D. Ludwig et al., Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases, DIG DIS SCI, 44(7), 1999, pp. 1440-1447
Authors:
Ludwig, D
Wiener, S
Bruning, A
Schwarting, K
Jantschek, G
Fellermann, K
Stahl, M
Stange, EF
Citation: D. Ludwig et al., Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study, GUT, 45(4), 1999, pp. 546-552